Bacillus Coagulans
Supplements · Probiotics · Supplement, Typed Supps
A shelf-stable probiotic that survives stomach acid unusually well, with early but small-scale evidence for easing IBS bloating and pain.
Stage by stage
- Intake (Capsule (spore form)): Taken orally, with or without food, thanks to spore acid-resistance.
- Stomach (Spore survival): The heat-resistant spore coat lets it survive gastric acid far better than non-spore probiotics.
- Intestine (Germination): Spores germinate into active bacteria and transiently colonize the gut.
- Symptom modulation (Gut motility and gas handling): Associated in small trials with reduced abdominal pain and bloating, particularly in IBS.
What the evidence supports
- Reducing abdominal pain and bloating in IBS — limited evidence. A small, placebo-controlled 8-week trial of the patented strain GBI-30, 6086 (marketed as GanedenBC30) found statistically significant weekly improvements in abdominal pain and bloating starting after one week. Promising, but the evidence base is a handful of small trials of one specific strain, not a large or diverse one.
- Improving symptoms of diarrhea-predominant IBS — limited evidence. A separate small randomized trial of the same strain reported symptom improvement, but again on a scale too small to be considered confirmatory.
- Evidence on Surviving gastric transit and room-temperature storage better than typical non-spore-forming probiotics — moderate evidence. The spore-forming trait is well documented in lab studies and simulated digestion models, giving it a genuine shelf-stability and acid-survival advantage — though this is a delivery advantage, not proof of a larger clinical benefit than other probiotic species.
Typical dose
0.8-2 billion CFU/day is what’s been used in the small IBS trials
Upper limit: No established UL
Timing
Take daily, with or without food — the spore form is acid-resistant either way.
Time to effect
- About one week: In the main IBS trial, improvements in pain and bloating were statistically significant starting from the first week.
Common myth
“Spore-forming means it works better than other probiotics.” In reality: The spore form genuinely survives stomach acid better — that’s well documented. But that’s a delivery advantage, not proof the clinical benefits are larger than those of other well-studied probiotic species; the disease-specific evidence here is still from a small number of trials.
More in Probiotics
In the glossary
Sources